MONTANOVA CAPITAL, LLC bought BNTC
December 23, 2025 · Form 4 insider transaction
MONTANOVA CAPITAL, LLC bought 42,600 shares of Benitec Biopharma Inc. at $12.85 per share, a transaction worth $547.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,600
Price
$12.85
Total value
$547.4K
InsiderMONTANOVA CAPITAL, LLC
RoleDirector, 10% owner
SecurityCommon stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateDecember 23, 2025
Filing dateDecember 29, 2025
Shares owned after9,620,075
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.